Veterinary Therapeutics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Description
Growth Factors of Veterinary Therapeutics Market
The global veterinary therapeutics market is experiencing significant growth, driven by increased pet ownership, rising demand for animal-derived products, and advancements in veterinary medicine. This sector encompasses a broad range of products designed to improve animal health and prevent diseases, including veterinary drugs, vaccines, and medicated feed additives.
Market Size and Forecast
In 2024, the global veterinary therapeutics market was valued at approximately USD 45.05 billion. Projections indicate that this market will expand to USD 70.66 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.9% during the forecast period .
Key Market Drivers
Several factors are contributing to the growth of the veterinary therapeutics market:
Increasing Pet Ownership: The rising number of households adopting pets has led to a higher demand for veterinary services and products.
Rising Incidence of Animal Diseases: The prevalence of zoonotic diseases, such as rabies and leptospirosis, along with infectious diseases like canine parvovirus and bovine mastitis, has heightened the need for effective veterinary therapeutics.
Advancements in Veterinary Medicine: Innovations in drug formulations, vaccine development, and diagnostic technologies have improved the efficacy of treatments available for animals.
Growing Demand for Animal-Derived Products: The increasing consumption of animal-based products has led to a greater focus on livestock health and productivity.
Market Segmentation
The veterinary therapeutics market can be segmented based on product type, animal type, route of administration, and distribution channel:
By Product Type:
Veterinary Drugs: Includes anti-infectives, anti-inflammatory drugs, and parasiticides.
Veterinary Vaccines: Comprises inactivated, live attenuated, and recombinant vaccines.
Medicated Feed Additives: Antimicrobials, anticoccidials, and antiparasitics used in animal feed.
By Animal Type:
Companion Animals: Such as dogs, cats, and avian species.
Livestock Animals: Including poultry, porcine, and bovine species.
By Route of Administration:
Oral: Administered through the mouth.
Parenteral: Administered via injection.
Topical: Applied directly to the skin.
Aerosol: Inhaled treatments.
By Distribution Channel:
Veterinary Hospitals and Clinics: Primary providers of veterinary services.
Pharmacies and Drug Stores: Retail outlets for veterinary medications.
Online Platforms: E-commerce sites offering veterinary products.
Regional Insights
North America: Dominated the market with a share of 39.51% in 2024, attributed to high healthcare standards for animals, a large pet population, and a robust veterinary infrastructure .
Asia Pacific: Expected to experience the highest growth rate during the forecast period, driven by increasing adoption of modern veterinary practices, government support for animal health initiatives, and rising pet ownership in countries like China and India.
Challenges and Opportunities
While the veterinary therapeutics market is poised for growth, it faces challenges such as regulatory hurdles, the high cost of advanced treatments, and concerns over antimicrobial resistance. However, these challenges also present opportunities for innovation in developing cost-effective and sustainable therapeutic solutions.
Conclusion
The veterinary therapeutics market is on a growth trajectory, fueled by factors such as increased pet ownership, rising animal disease incidences, and advancements in veterinary medicine. Stakeholders in the industry must navigate challenges while capitalizing on opportunities to meet the evolving needs of animal health care. As the market continues to expand, the focus on innovation and sustainability will be crucial in shaping the future of veterinary therapeutics.
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2024
Estimated Year 2025
Forecast Period 2025-2032
Historical Period 2019-2023
Unit Value (USD Billion)
Growth Rate CAGR of 5.9% from 2025-2032
Segmentation By Product
Veterinary Drugs
Anti-infectives
Anti-inflammatory
Parasiticides
Others
Veterinary Vaccines
o Inactivated
o Live Attenuated
o Recombinant
o Others
Medicated Feed Additives
Antimicrobials
Anticoccidials
Antiparasitics
Others
By Route of Administration
Oral
Parenteral
Topical
Aerosol
By Distribution Channel
Veterinary Hospitals
Veterinary Clinics
Pharmacies & Drug Stores
Others
By Region
North America (By Product, By Animal Type, Route of Administration, Distribution Channel, and Country)
U.S.
Canada
Europe (By Product, By Animal Type, Route of Administration, Distribution Channel, and Country/Sub-Region)
U.K.
Germany
France
Spain
Italy
Scandinavia
Rest of Europe
Asia Pacific (By Product, By Animal Type, By Route of Administration, By Distribution Channel, and Country/Sub-Region)
Japan
China
India
Australia
Southeast Asia
Rest of Asia Pacific
Latin America (By Product, Animal Type, Route of Administration, Distribution Channel, and Country/Sub-Region)
Brazil
Mexico
Rest of Latin America
Middle East & Africa (By Product, Animal Type, Route of Administration, Distribution Channel, and Country/Sub-Region)
GCC
South Africa
Rest of the Middle East & Africa
Please Note:
It will take 5-6 business days to complete the report upon order confirmation.
The global veterinary therapeutics market is experiencing significant growth, driven by increased pet ownership, rising demand for animal-derived products, and advancements in veterinary medicine. This sector encompasses a broad range of products designed to improve animal health and prevent diseases, including veterinary drugs, vaccines, and medicated feed additives.
Market Size and Forecast
In 2024, the global veterinary therapeutics market was valued at approximately USD 45.05 billion. Projections indicate that this market will expand to USD 70.66 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.9% during the forecast period .
Key Market Drivers
Several factors are contributing to the growth of the veterinary therapeutics market:
Increasing Pet Ownership: The rising number of households adopting pets has led to a higher demand for veterinary services and products.
Rising Incidence of Animal Diseases: The prevalence of zoonotic diseases, such as rabies and leptospirosis, along with infectious diseases like canine parvovirus and bovine mastitis, has heightened the need for effective veterinary therapeutics.
Advancements in Veterinary Medicine: Innovations in drug formulations, vaccine development, and diagnostic technologies have improved the efficacy of treatments available for animals.
Growing Demand for Animal-Derived Products: The increasing consumption of animal-based products has led to a greater focus on livestock health and productivity.
Market Segmentation
The veterinary therapeutics market can be segmented based on product type, animal type, route of administration, and distribution channel:
By Product Type:
Veterinary Drugs: Includes anti-infectives, anti-inflammatory drugs, and parasiticides.
Veterinary Vaccines: Comprises inactivated, live attenuated, and recombinant vaccines.
Medicated Feed Additives: Antimicrobials, anticoccidials, and antiparasitics used in animal feed.
By Animal Type:
Companion Animals: Such as dogs, cats, and avian species.
Livestock Animals: Including poultry, porcine, and bovine species.
By Route of Administration:
Oral: Administered through the mouth.
Parenteral: Administered via injection.
Topical: Applied directly to the skin.
Aerosol: Inhaled treatments.
By Distribution Channel:
Veterinary Hospitals and Clinics: Primary providers of veterinary services.
Pharmacies and Drug Stores: Retail outlets for veterinary medications.
Online Platforms: E-commerce sites offering veterinary products.
Regional Insights
North America: Dominated the market with a share of 39.51% in 2024, attributed to high healthcare standards for animals, a large pet population, and a robust veterinary infrastructure .
Asia Pacific: Expected to experience the highest growth rate during the forecast period, driven by increasing adoption of modern veterinary practices, government support for animal health initiatives, and rising pet ownership in countries like China and India.
Challenges and Opportunities
While the veterinary therapeutics market is poised for growth, it faces challenges such as regulatory hurdles, the high cost of advanced treatments, and concerns over antimicrobial resistance. However, these challenges also present opportunities for innovation in developing cost-effective and sustainable therapeutic solutions.
Conclusion
The veterinary therapeutics market is on a growth trajectory, fueled by factors such as increased pet ownership, rising animal disease incidences, and advancements in veterinary medicine. Stakeholders in the industry must navigate challenges while capitalizing on opportunities to meet the evolving needs of animal health care. As the market continues to expand, the focus on innovation and sustainability will be crucial in shaping the future of veterinary therapeutics.
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2024
Estimated Year 2025
Forecast Period 2025-2032
Historical Period 2019-2023
Unit Value (USD Billion)
Growth Rate CAGR of 5.9% from 2025-2032
Segmentation By Product
Veterinary Drugs
Anti-infectives
Anti-inflammatory
Parasiticides
Others
Veterinary Vaccines
o Inactivated
o Live Attenuated
o Recombinant
o Others
Medicated Feed Additives
Antimicrobials
Anticoccidials
Antiparasitics
Others
By Route of Administration
Oral
Parenteral
Topical
Aerosol
By Distribution Channel
Veterinary Hospitals
Veterinary Clinics
Pharmacies & Drug Stores
Others
By Region
North America (By Product, By Animal Type, Route of Administration, Distribution Channel, and Country)
U.S.
Canada
Europe (By Product, By Animal Type, Route of Administration, Distribution Channel, and Country/Sub-Region)
U.K.
Germany
France
Spain
Italy
Scandinavia
Rest of Europe
Asia Pacific (By Product, By Animal Type, By Route of Administration, By Distribution Channel, and Country/Sub-Region)
Japan
China
India
Australia
Southeast Asia
Rest of Asia Pacific
Latin America (By Product, Animal Type, Route of Administration, Distribution Channel, and Country/Sub-Region)
Brazil
Mexico
Rest of Latin America
Middle East & Africa (By Product, Animal Type, Route of Administration, Distribution Channel, and Country/Sub-Region)
GCC
South Africa
Rest of the Middle East & Africa
Please Note:
It will take 5-6 business days to complete the report upon order confirmation.
Table of Contents
150 Pages
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Overview of Animal Diseases by Key Countries, By Key Countries/ Region, 2024
- 4.2. Pipeline Analysis
- 4.3. Regulatory Scenario By Key Countries/ Region, 2024
- 4.4. Pricing Analysis
- 4.5. Pet Ownership Statistics, By Key Countries/ Region, 2024
- 4.6. Snapshot on the Novel & Upcoming Therapies
- 4.7. Overview of Treatment Plans for Different Animal Diseases
- 4.8. New Product Launches, By Key Players
- 4.9. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
- 4.10. Impact of COVID-19 on the Global Animal Health Market
- 5. Global Animal Health Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast – By Product
- 5.1.1. Veterinary Drugs
- 5.1.1.1. Anti-infectives
- 5.1.1.2. Anti-inflammatory
- 5.1.1.3. Parasiticides
- 5.1.1.4. Others
- 5.1.2. Veterinary Vaccines
- 5.1.2.1. Inactivated
- 5.1.2.2. Live Attenuated
- 5.1.2.3. Recombinant
- 5.1.2.4. Others
- 5.1.3. Medicated Feed Additives
- 5.1.3.1. Antimicrobials
- 5.1.3.2. Anti-coccidials
- 5.1.3.3. Antiparasitics
- 5.1.3.4. Others
- 5.2. Market Analysis, Insights and Forecast – By Animal Type
- 5.2.1. Companion
- 5.2.1.1. Feline
- 5.2.1.2. Canine
- 5.2.1.3. Avian
- 5.2.1.4. Others
- 5.2.2. Livestock
- 5.2.2.1. Poultry
- 5.2.2.2. Porcine
- 5.2.2.3. Bovine
- 5.2.2.4. Others
- 5.3. Market Analysis, Insights and Forecast – By Route of Administration
- 5.3.1. Oral
- 5.3.2. Parenteral
- 5.3.3. Topical
- 5.3.4. Aerosol
- 5.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 5.4.1. Veterinary Hospitals
- 5.4.2. Veterinary Clinics
- 5.4.3. Pharmacies & Drug Stores
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast – Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
- 6. North America Animal Health Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast – By Product
- 6.1.1. Veterinary Drugs
- 6.1.1.1. Anti-infectives
- 6.1.1.2. Anti-inflammatory
- 6.1.1.3. Parasiticides
- 6.1.1.4. Others
- 6.1.2. Veterinary Vaccines
- 6.1.2.1. Inactivated
- 6.1.2.2. Live Attenuated
- 6.1.2.3. Recombinant
- 6.1.2.4. Others
- 6.1.3. Medicated Feed Additives
- 6.1.3.1. Antimicrobials
- 6.1.3.2. Anti-coccidials
- 6.1.3.3. Antiparasitics
- 6.1.3.4. Others
- 6.2. Market Analysis, Insights and Forecast – By Animal Type
- 6.2.1. Companion
- 6.2.1.1. Feline
- 6.2.1.2. Canine
- 6.2.1.3. Avian
- 6.2.1.4. Others
- 6.2.2. Livestock
- 6.2.2.1. Poultry
- 6.2.2.2. Porcine
- 6.2.2.3. Bovine
- 6.2.2.4. Others
- 6.3. Market Analysis, Insights and Forecast – By Route of Administration
- 6.3.1. Oral
- 6.3.2. Parenteral
- 6.3.3. Topical
- 6.3.4. Aerosol
- 6.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 6.4.1. Veterinary Hospitals
- 6.4.2. Veterinary Clinics
- 6.4.3. Pharmacies & Drug Stores
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
- 7. Europe Animal Health Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast – By Product
- 7.1.1. Veterinary Drugs
- 7.1.1.1. Anti-infectives
- 7.1.1.2. Anti-inflammatory
- 7.1.1.3. Parasiticides
- 7.1.1.4. Others
- 7.1.2. Veterinary Vaccines
- 7.1.2.1. Inactivated
- 7.1.2.2. Live Attenuated
- 7.1.2.3. Recombinant
- 7.1.2.4. Others
- 7.1.3. Medicated Feed Additives
- 7.1.3.1. Antimicrobials
- 7.1.3.2. Anti-coccidials
- 7.1.3.3. Antiparasitics
- 7.1.3.4. Others
- 7.2. Market Analysis, Insights and Forecast – By Animal Type
- 7.2.1. Companion
- 7.2.1.1. Feline
- 7.2.1.2. Canine
- 7.2.1.3. Avian
- 7.2.1.4. Others
- 7.2.2. Livestock
- 7.2.2.1. Poultry
- 7.2.2.2. Porcine
- 7.2.2.3. Bovine
- 7.2.2.4. Others
- 7.3. Market Analysis, Insights and Forecast – By Route of Administration
- 7.3.1. Oral
- 7.3.2. Parenteral
- 7.3.3. Topical
- 7.3.4. Aerosol
- 7.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.4.1. Veterinary Hospitals
- 7.4.2. Veterinary Clinics
- 7.4.3. Pharmacies & Drug Stores
- 7.4.4. Others
- 7.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 7.5.1. Germany
- 7.5.2. U.K.
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
- 8. Asia Pacific Animal Health Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast – By Product
- 8.1.1. Veterinary Drugs
- 8.1.1.1. Anti-infectives
- 8.1.1.2. Anti-inflammatory
- 8.1.1.3. Parasiticides
- 8.1.1.4. Others
- 8.1.2. Veterinary Vaccines
- 8.1.2.1. Inactivated
- 8.1.2.2. Live Attenuated
- 8.1.2.3. Recombinant
- 8.1.2.4. Others
- 8.1.3. Medicated Feed Additives
- 8.1.3.1. Antimicrobials
- 8.1.3.2. Anti-coccidials
- 8.1.3.3. Antiparasitics
- 8.1.3.4. Others
- 8.2. Market Analysis, Insights and Forecast – By Animal Type
- 8.2.1. Companion
- 8.2.1.1. Feline
- 8.2.1.2. Canine
- 8.2.1.3. Avian
- 8.2.1.4. Others
- 8.2.2. Livestock
- 8.2.2.1. Poultry
- 8.2.2.2. Porcine
- 8.2.2.3. Bovine
- 8.2.2.4. Others
- 8.3. Market Analysis, Insights and Forecast – By Route of Administration
- 8.3.1. Oral
- 8.3.2. Parenteral
- 8.3.3. Topical
- 8.3.4. Aerosol
- 8.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.4.1. Veterinary Hospitals
- 8.4.2. Veterinary Clinics
- 8.4.3. Pharmacies & Drug Stores
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 8.5.1. China
- 8.5.2. Japan
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
- 9. Latin America Animal Health Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast – By Product
- 9.1.1. Veterinary Drugs
- 9.1.1.1. Anti-infectives
- 9.1.1.2. Anti-inflammatory
- 9.1.1.3. Parasiticides
- 9.1.1.4. Others
- 9.1.2. Veterinary Vaccines
- 9.1.2.1. Inactivated
- 9.1.2.2. Live Attenuated
- 9.1.2.3. Recombinant
- 9.1.2.4. Others
- 9.1.3. Medicated Feed Additives
- 9.1.3.1. Antimicrobials
- 9.1.3.2. Anti-coccidials
- 9.1.3.3. Antiparasitics
- 9.1.3.4. Others
- 9.2. Market Analysis, Insights and Forecast – By Animal Type
- 9.2.1. Companion
- 9.2.1.1. Feline
- 9.2.1.2. Canine
- 9.2.1.3. Avian
- 9.2.1.4. Others
- 9.2.2. Livestock
- 9.2.2.1. Poultry
- 9.2.2.2. Porcine
- 9.2.2.3. Bovine
- 9.2.2.4. Others
- 9.3. Market Analysis, Insights and Forecast – By Route of Administration
- 9.3.1. Oral
- 9.3.2. Parenteral
- 9.3.3. Topical
- 9.3.4. Aerosol
- 9.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 9.4.1. Veterinary Hospitals
- 9.4.2. Veterinary Clinics
- 9.4.3. Pharmacies & Drug Stores
- 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
- 10. Middle East & Africa Animal Health Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Market Analysis, Insights and Forecast – By Product
- 10.1.1. Veterinary Drugs
- 10.1.1.1. Anti-infectives
- 10.1.1.2. Anti-inflammatory
- 10.1.1.3. Parasiticides
- 10.1.1.4. Others
- 10.1.2. Veterinary Vaccines
- 10.1.2.1. Inactivated
- 10.1.2.2. Live Attenuated
- 10.1.2.3. Recombinant
- 10.1.2.4. Others
- 10.1.3. Medicated Feed Additives
- 10.1.3.1. Antimicrobials
- 10.1.3.2. Anti-coccidials
- 10.1.3.3. Antiparasitics
- 10.1.3.4. Others
- 10.2. Market Analysis, Insights and Forecast – By Animal Type
- 10.2.1. Companion
- 10.2.1.1. Feline
- 10.2.1.2. Canine
- 10.2.1.3. Avian
- 10.2.1.4. Others
- 10.2.2. Livestock
- 10.2.2.1. Poultry
- 10.2.2.2. Porcine
- 10.2.2.3. Bovine
- 10.2.2.4. Others
- 10.3. Market Analysis, Insights and Forecast – By Route of Administration
- 10.3.1. Oral
- 10.3.2. Parenteral
- 10.3.3. Topical
- 10.3.4. Aerosol
- 10.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 10.4.1. Veterinary Hospitals
- 10.4.2. Veterinary Clinics
- 10.4.3. Pharmacies & Drug Stores
- 10.4.4. Others
- 10.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis (2024)
- 11.2. Company Profiles
- 11.2.1. Zoetis Services LLC
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Merck Animal Health
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Elanco
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Boehringer Ingelheim International GmbH.
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Ceva
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Vetoquinol
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Virbac
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Phibro Animal Health Corporation
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. Panav Bio Tech.
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
